Navigation Links
Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
Date:4/1/2013

egeneration of native-like urinary tissue for bladder cancer patients requiring a urinary diversion following bladder removal. The Company plans to initiate a Phase 1 clinical trial in Sweden during the second quarter of 2013 for the Neo-Kidney Augment™, which is designed to prevent or delay dialysis kidney transplantation by increasing renal function in patients with advanced chronic kidney disease. Tengion has worldwide rights to its product candidates.

Forward-Looking Statements

Certain statements set forth above may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements using words such as anticipate, expect, project, intend, plan, believe, words and terms of similar substance and any discussion of future plans, actions, or events generally identify forward-looking statements. Forward-looking statements regarding the Company include but are not limited to (i) plans to develop and commercialize its product candidates, including the Neo-Urinary Conduit and the Neo-Kidney Augment; and (ii) expectations regarding ongoing and planned preclinical studies, clinical trials and related filings or submissions with regulatory authorities.  Although Tengion believes that these statements are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there are a number of factors that may cause actual results to differ from these statements. Tengion's business is subject to significant risks and uncertainties and there can be no assurance that actual results will not differ materially from expectations.  Factors which could cause actual results to differ materially from expectations include, among others: (i) the U.S. Food and Drug Administration could place the Neo-Urinary Conduit clinical trial on clinical hold; (ii) the Medical Products Agency could place the Neo-Kidney Augment clinical trial on clinical ho
'/>"/>

SOURCE Tengion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tengion Reports Second Quarter 2012 Financial Results
2. Tengion to Present at the BIO CEO & Investor Conference
3. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
4. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
5. Nephros Receives 510(k) Clearance for Hemodiafiltration System
6. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
7. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
8. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
9. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
10. Alexza Receives Complete Response Letter for Adasuve™ NDA
11. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
(Date:8/28/2014)... , August 28, 2014 ... titled, "DNA diagnostics Market (products, applications, techniques, end ... Opportunities, Growth and Forecast, 2013 - 2020," indicates ... $19 billion by 2020 registering a CAGR of ... provide accurate diagnosis and cost effectiveness over alternative ...
(Date:8/28/2014)... Aug. 28, 2014 /PRNewswire-iReach/ -- Gateway Analytical announced ... 9 th Annual Global Pharma Manufacturing Summit ... 8-9 th . The Global Pharma Manufacturing Summit ... small molecule and biologic pharmaceutical manufacturing. The conference ... today,s manufacturers face, such as the increasing pressure ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
... Lloydspharmacy, the community pharmacy chain, has revealed that one in ... million** adults - has taken or applied medicines which they later ... more than half (53%) of people do not always check the ... a family member. This is worrying considering that ...
... 2011 ORFLO Technologies announced the international launch of ... automated cell counter at the American Association for Cancer ... http://photos.prnewswire.com/prnh/20110403/SF76326 ) "The Moxi Z ... cell counting community," said Manju Sethi, Vice President of ...
Cached Medicine Technology:Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3ORFLO Launches First Hands-free Mini Automated Cell Counter 2
(Date:8/29/2014)... Most dentists work during normal business hours. That means ... day to be able to go see the dentist. It ... few hours during their increasingly busy days. That is what ... is now possible for people to get the preventative and ... , North York Dental has realized that it is difficult ...
(Date:8/29/2014)... ALS, more commonly referred to as Lou Gehrig’s ... in the brain and spinal cord. As the disease ... are harmed, which causes the sufferer to lose control of ... ALS is a disease that strikes people between the ages ... have the disease at any given time. , Although ...
(Date:8/29/2014)... Top10BestSEOHosting.com today compares many professional Windows ... that Bluehost ( http://www.bluehost.com/track/seohosts ), Arvixe, and Hostgator ... webmasters who want to buy high quality WordPress ... affordable rates. , Bluehost is also a popular ... features is that Bluehost provides quality hosting and ...
(Date:8/29/2014)... According to The Madison-St. Clair Record, ... Greenstone LLC and Pfizer R&D Cortex District alleging that ... a result of using Zoloft during her pregnancy ... St. Clair County Circuit Court (Case No. 14-L-594) on ... companies allegedly concealed the risks of serious birth defects ...
(Date:8/29/2014)... Visiting Nurse Association of Northern New Jersey ... comfort and companionship to terminally-ill patients and their families. ... to grow and their needs expand, the VNA offers ... next Hospice Training Program will be offered on Saturday, ... at VNA’s headquarters, 175 South Street in Morristown. ...
Breaking Medicine News(10 mins):Health News:North York Dental Provides Dental Services to Busy Professionals 2Health News:Charity Event to Raise Awareness and Donations for the ALS Foundation 2Health News:Top10BestSEOHosting.com: Bluehost, Arvixe, and Hostgator Are the Best Windows Web Hosting from the USA in 2014 2Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Zoloft Birth Defect Lawsuit 2Health News:VNA Offers Rewarding Hospice Volunteer Opportunity 2Health News:VNA Offers Rewarding Hospice Volunteer Opportunity 3
... has been given a clear idea about the expectations ... in the midst of psychiatric treatments. While// acknowledging the ... the deputy health minister pressed the need for further ... ,Mr. McDonald said: "It's vital that the State ...
... lesbians and single women as heterosexual couples, according to the ... by the British Fertility Society in a series of recommendations ... for acceptance on to an NHS programme of treatment. ... Local Health Boards also include telling obese women to lose ...
... "downer" used to get relief from mental stress and ... the banning of the// drug in most countries. ... pharmaceutical market as non-addictive sleeping pills and was also ... blood pressure and anxiety attacks. ,However, the ...
... milk is healthier than standard milk and this should be ... ,The 14 prominent scientists, who were led by ... Food Standards Agency that organic milk has higher levels of ... ,They expect a change in stance of the ...
... have warned the patients to be wary of the so-called ... most have not been properly tested.// ,The health ... UK for establishing herself as a world leader in stem ... those for multiple sclerosis and cosmetic skin treatment were yet ...
... the University of California said in a new study ... damage skin. // Filters used in sunscreen to keep ... generated by the UV radiation can harm the skin.,One ... skin damage and hastens aging process. 'Sunscreens do ...
Cached Medicine News:Health News:Delhi Police Seized 4,400 kg of Banned Drug Mandrax 2Health News:More Health Benefits from Organic milk 2Health News:Scientists In UK Issue A Caution Over Untested Stem Cell Treatments 2
... research model of the Bowman Perfusion Monitor ... continuously in real-time. This precision instrument activates ... which is connected by an umbilical cord ... digital form and send the data to ...
Housed in a small lightweight, flame retardant plastic cases, meters are equipped with a convenient multiposition handle/stand. Measure microcirculation in 1 cubic mm of tissue for real-time assessme...
... featured laser doppler system for continuous ... multiple tissue sites. This latest generation ... Processing (DSP) and laser Doppler flowmetry ... to use, multi-channel monitor, setting new ...
Transcranial vascular DWL doppler....
Medicine Products: